Sergio
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Institute Catalá Oncología
Barcelona, España
Publications in collaboration with researchers from Institute Catalá Oncología (2)
2025
-
Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study
Clinical and Translational Oncology, Vol. 27, Núm. 6, pp. 2719-2730
-
Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 31, Núm. 9, pp. 1644-1656